Medtronic Launches Low-Cost Hip and Knee Program, Forecasts Surgical Robot Revenue By FY 2019

Medtronic expects "material revenue" from its new robotic surgery business in fiscal year 2019, company executives said during Medtronic's investor day presentation held recently. They also unveiled plans to offer value-based hip and knee replacement devices, and confirmed submission for FDA approval of the first "hybrid closed loop" insulin pump.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news